The efficacy of a 24-hour preoperative pause for SGLT2-inhibitors in type II diabetes patients undergoing bariatric surgery to mitigate euglycemic diabetic ketoacidosis - 03/02/24
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
The case emphasizes the risk of euglycemic diabetic ketoacidosis (DKA) after bariatric surgery and SGLT2 inhibitor use, highlighting the importance of patient education and healthcare provider monitoring. Potential causes include increased urinary glucose excretion from SGLT2 inhibitors, reduced carbohydrate intake post-surgery, and possible insulin discontinuation effects. The current recommendation from AACE to discontinue SGLT2 inhibitors 24 h before surgery may require additional research to determine the optimal timing of discontinuation.
Le texte complet de cet article est disponible en PDF.Plan
Vol 14
Article 100201- avril 2024 Retour au numéro
Article précédent
- Oral semaglutide effectiveness and safety in real world practice; The REVOLUTION study
- Abdulrahman Alsheikh, Ali Alshehri, Saad Alzahrani, Anwar AlJammah, Fahad Alqahtani, Metib Alotaibi, Raed Aldahash, Amani M. Alhozali, Fahad Alsabaan, Mohammed Almehthel, Naser Aljuhani, Ali Aldabeis, Moneer Alamri, Waleed Maghawry, Naweed Alzaman, Alshaima Alshaikh, Omar M. Alnozha, Emad R Issak, Saud Alsifri
- Addressing common sources of bias in studies of new-onset type 2 diabetes following COVID that use electronic health record data
- Jessica L Harding, Emily Pfaff, Edward Boyko, Pandora L. Wander
Bienvenue sur EM-consulte, la référence des professionnels de santé.